ストックスクリーナーアプリを入手
129.67
0.07%
0.09
アフターアワーズ：
130.50
0.83
+0.64%
前日終値:
$129.58
開ける：
$130.15
24時間の取引高:
5.18M
Relative Volume:
0.84
時価総額：
$160.99B
収益：
$29.79B
当期純損益:
$9.22B
株価収益率:
17.64
EPS:
7.3494
ネットキャッシュフロー:
$10.23B
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
-5.79%
6か月 パフォーマンス:
+1.96%
1年 パフォーマンス:
+26.51%
1日の値動き範囲:
$129.22
$131.05
1週間の範囲:
$129.09
$137.50
52週間の値動き範囲:
$102.84
$157.29
Gilead Sciences Inc Stock (GILD) Company Profile
Compare GILD vs LLY, JNJ, ABBV, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
129.67 | 160.88B | 29.79B | 9.22B | 10.23B | 7.3494 |
LLY
Lilly Eli Co
|
988.09 | 896.13B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
228.92 | 545.74B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
209.41 | 371.72B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
183.92 | 281.60B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
149.15 | 282.55B | 54.66B | 13.58B | 16.05B | 7.0171 |
Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | 開始されました | Jefferies | Buy |
| 2026-02-20 | 開始されました | Barclays | Equal Weight |
| 2026-02-11 | 繰り返されました | Needham | Buy |
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-08-19 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | アップグレード | Truist | Hold → Buy |
| 2025-07-25 | アップグレード | Needham | Hold → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 繰り返されました | Oppenheimer | Outperform |
| 2025-02-18 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-13 | アップグレード | DZ Bank | Hold → Buy |
| 2025-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-11-08 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 繰り返されました | Maxim Group | Buy |
| 2024-04-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-02-22 | ダウングレード | Truist | Buy → Hold |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Reduce |
| 2023-07-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-16 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 再開されました | Piper Sandler | Overweight |
| 2023-01-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 再開されました | BofA Securities | Neutral |
| 2022-12-09 | ダウングレード | DZ Bank | Buy → Hold |
| 2022-10-31 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2022-10-28 | 繰り返されました | Cowen | Outperform |
| 2022-10-28 | 繰り返されました | JP Morgan | Overweight |
| 2022-10-28 | 繰り返されました | Jefferies | Buy |
| 2022-10-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-10-28 | アップグレード | Truist | Hold → Buy |
| 2022-10-28 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-10-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-28 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-02 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-02 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-02-02 | 繰り返されました | Truist | Hold |
| 2022-02-02 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Argus | Hold → Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 再開されました | Piper Sandler | Neutral |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-07-30 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2021-07-30 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2021-04-01 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-01-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-09-30 | 再開されました | Jefferies | Buy |
| 2020-09-15 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-31 | 繰り返されました | Credit Suisse | Neutral |
| 2020-07-31 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 繰り返されました | Piper Sandler | Overweight |
| 2020-07-31 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2020-07-31 | 繰り返されました | SunTrust | Hold |
| 2020-07-31 | 繰り返されました | Wells Fargo | Equal Weight |
| 2020-07-20 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | アップグレード | SunTrust | Sell → Hold |
| 2020-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-05-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | ダウングレード | SunTrust | Hold → Sell |
| 2020-04-27 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
すべてを表示
Gilead Sciences Inc (GILD) 最新ニュース
Gilead (GILD) executive sells 28,000 shares, exercises 25,000 options - Stock Titan
Gilead Sciences (NASDAQ: GILD) sells $3.0B of senior notes due 2028–2034 - Stock Titan
Cipla Flips Gilead’s ‘End Run’ Claim in Descovy Patent Fight - Bloomberg Law News
Gilead Sciences’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
WealthPlan Investment Management LLC Acquires 10,256 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
TD Private Client Wealth LLC Acquires 17,944 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
45,461 Shares in Gilead Sciences, Inc. $GILD Purchased by North Dakota State Investment Board - MarketBeat
Erste Group Bank Predicts Gilead Sciences FY2026 Earnings - MarketBeat
Gilead Sciences Inc stock (US3755581036): dividend growth and HIV/oncology pipeline in focus - AD HOC NEWS
Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline - MarketBeat
Leuthold Group LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
L & S Advisors Inc Invests $5.09 Million in Gilead Sciences, Inc. $GILD - MarketBeat
iA Global Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD - MarketBeat
STF Management LP Sells 11,745 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
DNB Asset Management AS Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Canada Post Corp Registered Pension Plan - MarketBeat
Abacus Wealth Partners LLC Buys Shares of 12,486 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences to buy clinical-stage biotech Tubulis for up to $5 billion - MSN
Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority Review - Yahoo Finance
Gilead Sciences Inc stock (US3755581036): Insider share sale plans draw attention to valuation and p - AD HOC NEWS
Gilead Sciences, Inc. $GILD Shares Acquired by Commerzbank Aktiengesellschaft FI - MarketBeat
Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch
Andrew Dickinson to sell 3,000 GILD shares, Form 144 (NASDAQ: GILD) - Stock Titan
Officer files Form 144 — GILD (NASDAQ: GILD) lists 25,000-share option sale - Stock Titan
Latham & Watkins Advises on Gilead Sciences’ US$3 Billion Senior Unsecured Notes Offering - Latham & Watkins LLP
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD) - The Globe and Mail
Gilead Sciences prices $3B multi-tranche senior notes offering - MSN
Gilead Sciences Prices $3 Billion Debt Offering - Moomoo
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - MarketBeat
Atria Investments Inc Acquires 12,906 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Prices $3B Senior Unsecured Notes Offerin - GuruFocus
Arbejdsmarkedets Tillaegspension Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position - MarketBeat
Ameritas Advisory Services LLC Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
GILD Stock Price, Quote & Chart | GILEAD SCIENCES INC (NASDAQ:GILD) - ChartMill
Gilead Prices $3 Billion of Senior Unsecured Notes - New Castle News
Gilead Sciences stock (US3755581036): Q1 earnings, FDA timing and investor focus - AD HOC NEWS
Gilead Sciences Just Told Investors What to Watch Before December 23. Here’s What the Data Says About GILD Stock. - TIKR.com
Gilead Sciences launches bond offering after acquisition spreeBloomberg By Investing.com - Investing.com South Africa
Gilead Sciences (GILD) files for multi‑tranche senior unsecured note offering - Stock Titan
Oppenheimer Remains a Buy on Gilead Sciences (GILD) - The Globe and Mail
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 - BioSpace
Bay Area biotech giant Gilead to lay off 108 workers in Redwood City - MSN
Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views? - Yahoo Finance
Gilead’s Transition Into A Long-Duration Biotech Platform (NASDAQ:GILD) - Seeking Alpha
Gilead to present liver disease data at EASL conference By Investing.com - Investing.com Canada
Oppenheimer Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165 - Moomoo
Gilead Sciences, Inc. $GILD Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Trek Financial LLC Purchases 13,041 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Inc (GILD) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
0.00%
大文字化:
|
ボリューム (24 時間):